Pfizer
Pfizer Performance
Day Range
- Low 4,050.00
- High 4,091.05
52 Week Range
- Low 3,408.00
- High 4,560.00
- Open Price4,050.00
- Previous Close4,043.50
- Volume16224
Start SIP in Pfizer
Start SIPPfizer Investment Rating
-
Master Rating:
-
Pfizer (Nse) has an operating revenue of Rs. 2,300.96 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 34% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 2% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 575 | 531 | 573 | 622 | 637 | 593 | 550 |
Operating Expenses Qtr Cr | 393 | 421 | 391 | 418 | 406 | 401 | 384 |
Operating Profit Qtr Cr | 183 | 111 | 182 | 203 | 232 | 192 | 165 |
Depreciation Qtr Cr | 15 | 16 | 26 | 26 | 26 | 27 | 34 |
Interest Qtr Cr | 3 | 3 | 3 | 4 | 3 | 4 | 4 |
Tax Qtr Cr | 52 | 32 | 35 | 50 | 104 | 11 | 19 |
Net Profit Qtr Cr | 149 | 94 | 130 | 151 | 311 | 33 | 126 |
Pfizer Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹4,027.73
- 50 Day
- ₹3,977.55
- 100 Day
- ₹3,939.74
- 200 Day
- ₹3,953.82
- 20 Day
- ₹4,021.47
- 50 Day
- ₹3,967.35
- 100 Day
- ₹3,928.52
- 200 Day
- ₹3,844.63
Pfizer Resistance and Support
Resistance | |
---|---|
First Resistance | 4,097.77 |
Second Resistance | 4,114.93 |
Third Resistance | 4,138.82 |
RSI | 59.85 |
MFI | 50.23 |
MACD Single Line | 34.30 |
MACD | 33.08 |
Support | |
---|---|
First Resistance | 4,056.72 |
Second Resistance | 4,032.83 |
Third Resistance | 4,015.67 |
Pfizer Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 17,838 | 1,010,344 | 56.64 |
Week | 34,905 | 2,693,952 | 77.18 |
1 Month | 21,167 | 1,255,641 | 59.32 |
6 Month | 26,315 | 1,813,609 | 68.92 |
Pfizer Result Highlights
Pfizer Synopsis
NSE-Medical-Diversified
Pfizer Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2424.76 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2023. Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311.Market Cap | 18,668 |
Sales | 2,301 |
Shares in Float | 1.65 |
No of funds | 119 |
Yield | 0.86 |
Book Value | 5.82 |
U/D Vol ratio | 2.4 |
LTDebt / Equity | |
Alpha | -0.05 |
Beta | 0.32 |
Pfizer
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 63.92% | 63.92% | 63.92% | 63.92% |
Mutual Funds | 7.39% | 6.17% | 5.96% | 5.97% |
Insurance Companies | 7.57% | 8.68% | 8.89% | 8.91% |
Foreign Portfolio Investors | 2.82% | 2.81% | 2.8% | 2.77% |
Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.02% |
Individual Investors | 13.61% | 13.68% | 13.7% | 13.72% |
Others | 4.68% | 4.73% | 4.72% | 4.69% |
Pfizer Management
Name | Designation |
---|---|
Ms. Meenakshi Nevatia | Managing Director |
Mr. Milind Patil | Executive Director (Finance) & CFO |
Mr. Samir Kazi | Executive Director |
Mr. Sunil Lalbhai | Independent Director |
Mr. Pradip Shah | Chairman & Ind.Director |
Mr. Uday Khanna | Independent Director |
Ms. Meena Ganesh | Independent Director |
Pfizer Forecast
Price Estimates
Pfizer Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-10-28 | Quarterly Results | |
2023-08-11 | Quarterly Results | |
2023-05-15 | Audited Results & Final Dividend | |
2023-02-09 | Quarterly Results | |
2022-11-11 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-08-11 | FINAL | Rs.35.00 per share(350%)Final Dividend |
2023-08-11 | SPECIAL | Rs.5.00 per share(50%)Special Dividend |
2022-09-20 | SPECIAL | Rs.30.00 per share (300%) Special Interim Dividend |
2022-08-19 | FINAL | Rs.35.00 per share(350%)Dividend |
Pfizer FAQs
What is Share Price of Pfizer ?
Pfizer share price is ₹4,080 As on 10 December, 2023 | 21:37
What is the Market Cap of Pfizer ?
The Market Cap of Pfizer is ₹18667.8 Cr As on 10 December, 2023 | 21:37
What is the P/E ratio of Pfizer ?
The P/E ratio of Pfizer is 35.7 As on 10 December, 2023 | 21:37
What is the PB ratio of Pfizer ?
The PB ratio of Pfizer is 5.8 As on 10 December, 2023 | 21:37